Biogen Overview
Biogen Target Price
Analysts' 12-month price predictions for BIIB.
Share Price
$230.57
Average Target Price
$263.40
14.2% upside
14.2% upside5 analysts in the last 4 months
High: $317 | Low: $215
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-25 | WedbushLaura Chico | $215 |  6.8% downside |  |
| 2024-04-25 | H.C. WainwrightAndrew Fein | $300 | 30.1% upside | |
| 2024-04-25 | RBC CapitalBrian Abrahams | $317 | 37.5% upside | |
| 2024-04-19 | OppenheimerJay Olson | $270 | 17.1% upside | |
| 2024-04-03 | BarclaysCarter Gould | $215 | 6.8% downside | |
| 2023-08-07 | WedbushLaura Chico | $269 | 16.7% upside | |
| 2023-05-01 | GuggenheimYatin Suneja | $350 | 51.8% upside | |
| 2022-12-01 | Atlantic Equities | $295 | 27.9% upside | |
| 2022-11-30 | Jefferies | $350 | 51.8% upside | |
| 2022-11-30 | Wedbush | $247 | 7.1% upside | |
| 2022-11-30 | Barclays | $313 | 35.8% upside | |
| 2022-11-15 | Truist Financial | $350 | 51.8% upside | |
| 2022-11-11 | Guggenheim | $270 | 17.1% upside | |
| 2022-09-30 | J.P. Morgan | $275 | 19.3% upside | |
| 2022-09-28 | NeedhamAmi Fadia | $250 | 8.4% upside | |
| 2022-09-28 | Morgan StanleyMatthew Harrison | $285 | 23.6% upside | |
| 2022-09-28 | Atlantic EquitiesSteve Chesney | $200 | 13.3% downside | |
| 2022-09-28 | Wedbush | $217 | 5.9% downside | |
| 2022-09-28 | Wells Fargo | $350 | 51.8% upside | |
| 2022-09-28 | RBC Capital | $321 | 39.2% upside | |
| 2022-09-28 | Piper Sandler | $280 | 21.4% upside | |
| 2022-09-28 | BMO CapitalEvan David Seigerman | $360 | 56.1% upside | |
| 2022-09-28 | Mizuho SecuritiesSalim Syed | $270 | 17.1% upside | |
| 2022-09-28 | Robert W. BairdBrian Skorney | $340 | 47.5% upside | |
| 2022-09-28 | NeedhamAmi Fadia | $250 | 8.4% upside | |
| 2022-09-22 | Truist Financial | $265 | 14.9% upside | |
| 2022-09-12 | Stifel Nicolaus | $223 | 3.3% downside | |
| 2022-07-21 | Cowen & Co. | $270 | 17.1% upside | |
| 2022-07-21 | Truist Financial | $270 | 17.1% upside | |
| 2022-07-21 | Barclays | $200 | 13.3% downside | |
| 2022-07-18 | Oppenheimer | $230 | 0.2% downside | |
| 2022-05-04 | Barclays | $210 | 8.9% downside | |
| 2022-04-21 | Leerink Partners | $270 | 17.1% upside | |
| 2022-04-18 | Wells FargoMohit Bansal | $265 | 14.9% upside | |
| 2022-04-16 | BarclaysCarter Gould | $219 | 5% downside | |
| 2022-04-11 | NeedhamAmi Fadia | $262 | 13.6% upside | |
| 2022-04-09 | WedbushLaura Chico | $185 | 19.8% downside | |
| 2022-04-07 | Robert W. BairdBrian Skorney | $224 | 2.8% downside | |
| 2022-04-07 | Piper SandlerChristopher Raymond | $200 | 13.3% downside | |
| 2022-04-07 | JefferiesMichael Yee | $300 | 30.1% upside | |
| 2022-04-05 | RBC CapitalBrian Abrahams | $244 | 5.8% upside | |
| 2022-03-28 | Bank of America SecuritiesGeoff Meacham | $225 | 2.4% downside | |
| 2022-03-15 | BMO CapitalEvan Seigerman | $238 | 3.2% upside | |
| 2022-02-28 | Canaccord GenuitySumant Kulkarni | $285 | 23.6% upside | |
| 2022-02-22 | GuggenheimYatin Suneja | $200 | 13.3% downside | |
| 2022-02-16 | Truist FinancialRobyn Karnauskas | $320 | 38.8% upside | |
| 2022-02-13 | NeedhamAmi Fadia | $290 | 25.8% upside | |
| 2022-02-07 | Mizuho SecuritiesSalim Syed | $207 | 10.2% downside | |
| 2022-02-04 | Wells FargoMohit Bansal | $235 | 1.9% upside | |
| 2022-02-04 | BarclaysCarter Gould | $235 | 1.9% upside | |